<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD002299.pub2" GROUP_ID="UPPERGI" ID="738700082422405718" MERGED_FROM="" MODIFIED="2010-09-21 21:27:12 +0200" MODIFIED_BY="Karin Dearness" REVIEW_NO="26" REVMAN_SUB_VERSION="5.0.23" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="12.1">
<COVER_SHEET MODIFIED="2010-09-21 21:27:12 +0200" MODIFIED_BY="Karin Dearness">
<TITLE>Nitrates for achalasia</TITLE>
<CONTACT MODIFIED="2010-09-21 21:27:12 +0200" MODIFIED_BY="Karin Dearness"><PERSON ID="16718" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Zhonghui</FIRST_NAME><LAST_NAME>Wen</LAST_NAME><EMAIL_1>zhwen05@gmail.com</EMAIL_1><EMAIL_2>zhwen05@gmail.com</EMAIL_2><ADDRESS><DEPARTMENT>Department of Digestive Disease</DEPARTMENT><ORGANISATION>West China Hospital, Sichuan University</ORGANISATION><ADDRESS_1>No. 37, Guo Xue Xiang</ADDRESS_1><CITY>Chengdu</CITY><ZIP>610041</ZIP><REGION>Sichuan</REGION><COUNTRY CODE="CN">China</COUNTRY></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2010-09-21 21:27:12 +0200" MODIFIED_BY="Karin Dearness"><PERSON ID="16718" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Zhonghui</FIRST_NAME><LAST_NAME>Wen</LAST_NAME><EMAIL_1>zhwen05@gmail.com</EMAIL_1><EMAIL_2>zhwen05@gmail.com</EMAIL_2><ADDRESS><DEPARTMENT>Department of Digestive Disease</DEPARTMENT><ORGANISATION>West China Hospital, Sichuan University</ORGANISATION><ADDRESS_1>No. 37, Guo Xue Xiang</ADDRESS_1><CITY>Chengdu</CITY><ZIP>610041</ZIP><REGION>Sichuan</REGION><COUNTRY CODE="CN">China</COUNTRY></ADDRESS></PERSON><PERSON ID="14348" ROLE="AUTHOR"><FIRST_NAME>Elizabeth</FIRST_NAME><LAST_NAME>Gardener</LAST_NAME><POSITION>Medical Statistician</POSITION><EMAIL_1>liz.gardener@phpc.cam.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Department of Public Health and Primary Care</DEPARTMENT><ORGANISATION>University of Cambridge</ORGANISATION><ADDRESS_1>Institute of Public Health, Forvie Site</ADDRESS_1><ADDRESS_2>Robinson Way</ADDRESS_2><CITY>Cambridge</CITY><ZIP>CB2 2SR</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>44 122  333 0344</PHONE_1><FAX_1>44 122 333 0330</FAX_1></ADDRESS></PERSON><PERSON ID="1DA7B8D682E26AA2004A583D1186241F" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Yiping</FIRST_NAME><LAST_NAME>Wang</LAST_NAME><POSITION>Professor</POSITION><EMAIL_1>wyiping2006@yahoo.com.cn</EMAIL_1><EMAIL_2>wyiping2002@yahoo.com</EMAIL_2><ADDRESS><DEPARTMENT>Department of Digestive Disease</DEPARTMENT><ORGANISATION>West China Hospital, Sichuan University</ORGANISATION><ADDRESS_1>No. 37, Guo Xue Xiang</ADDRESS_1><CITY>Chengdu</CITY><ZIP>610041</ZIP><REGION>Sichuan</REGION><COUNTRY CODE="CN">China</COUNTRY><PHONE_1>+86 28 8554 4437</PHONE_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2010-02-03 17:00:54 +0000" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="3" MONTH="2" YEAR="2010"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="2" MONTH="12" YEAR="2008"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="3" MONTH="2" YEAR="2012"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2000"/>
<REVIEW_PUBLISHED ISSUE="4" YEAR="2002"/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="2004"/>
</DATES>
<WHATS_NEW MODIFIED="2010-09-21 21:27:12 +0200" MODIFIED_BY="Karin Dearness"><WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-09-21 21:27:12 +0200" MODIFIED_BY="Karin Dearness"><DATE DAY="21" MONTH="9" YEAR="2010"/><DESCRIPTION><P>Contact details updated.</P></DESCRIPTION></WHATS_NEW_ENTRY>

<WHATS_NEW_ENTRY EVENT="STABLE" MODIFIED="2010-02-03 18:47:20 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="3" MONTH="2" YEAR="2010"/>
<DESCRIPTION>
<P>Searches, tables and figures last updated February 2010. Declared stable and no future updates planned.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2010-09-21 21:27:12 +0200" MODIFIED_BY="Karin Dearness"><WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2010-09-21 21:27:12 +0200" MODIFIED_BY="Karin Dearness">
<DATE DAY="3" MONTH="2" YEAR="2010"/>
<DESCRIPTION>
<P>Updated</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-04-10 13:31:43 +0100" MODIFIED_BY="Cathy Bennett">
<DATE DAY="30" MONTH="10" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2009-04-10 13:31:46 +0100" MODIFIED_BY="Cathy Bennett">
<DATE DAY="13" MONTH="9" YEAR="2005"/>
<DESCRIPTION>
<P>New studies sought but none found</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-04-10 13:31:48 +0100" MODIFIED_BY="Cathy Bennett">
<DATE DAY="21" MONTH="8" YEAR="2002"/>
<DESCRIPTION>
<P>Minor update</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Chinese Cochrane Centre, Chinese Centre of Evidence-based Medicine, West China Hospital of Sichuan University</NAME>
<COUNTRY CODE="CN">China</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>China Medical Board of New York (Grant number: 98-680)</NAME>
<COUNTRY CODE="CN">China</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2010-02-24 10:29:13 +0000" MODIFIED_BY="Cathy Bennett">
<SUMMARY MODIFIED="2010-02-12 09:47:51 +0000" MODIFIED_BY="Cathy Bennett">
<TITLE MODIFIED="2009-04-10 13:35:46 +0100" MODIFIED_BY="Cathy Bennett">Nitrates (medicines) for achalasia (impaired swallowing)</TITLE>
<SUMMARY_BODY MODIFIED="2010-02-12 09:47:51 +0000" MODIFIED_BY="Cathy Bennett">
<P>Achalasia is a condition where the lower part of the oesophagus leading to the stomach is unable to relax normally after swallowing. Food may become stuck there rather than going through into the stomach. Although the cause of achalasia is not known, it is well demonstrated that loss of oesophageal neurons is the underlying problem. Patients may experience dysphagia, regurgitation of food, retrosternal pain and so on. Nitrates are drugs that may relax the muscle and they are used to try to relieve the symptoms. They can be taken either as tablets, or absorbed under the tongue. Nitrates can be used in patients with mild symptoms, where it is not necessary to perform an invasive procedure such as surgery or if the patient is not a suitable candidate for surgery for some other reason. Nitrates can also be used if there is no response to injections of botulinum toxin to relax the muscle of the oesophagus. One other widely used option for the treatment of achalasia is dilation of the oesophagus using endoscopic methods. This review found there is not enough evidence from trials to show if nitrates are an effective treatment to relieve achalasia.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2010-02-12 09:47:30 +0000" MODIFIED_BY="Cathy Bennett">
<ABS_BACKGROUND MODIFIED="2010-02-12 09:47:30 +0000" MODIFIED_BY="Cathy Bennett">
<P>Achalasia is a disease that impairs oesophageal motility. Although nitrates have been used to treat achalasia for a long time, the effectiveness of nitrates for achalasia is still controversial. Newer therapies have to some extent superceded the use of nitrates for achalasia, but nitrates may still be used in early or mild disease, in patients who are unsuitable for surgery or invasive procedures, or when botulinum injection therapy has failed.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2010-02-03 18:02:31 +0000" MODIFIED_BY="[Empty name]">
<P>To quantify short-term and long-term effects of nitrate therapy in participants with achalasia.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2009-04-10 13:49:47 +0100" MODIFIED_BY="Cathy Bennett">
<P>Trials were identified by searching the Cochrane Controlled Trials Register (Issue 4-2001), MEDLINE (1966-2001), EMBASE (1980-2001), LILACS - Latin American and Caribbean health science literature (1982-2001) and CBM-Chinese Biomedical database(1980-2000). Additionally, all references in the identified trials were checked for further relevant trials. An updated search was run on the Cochrane Library, MEDLINE, and EMBASE in September 2003, October 2004, September 2005 and December 2008.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2010-02-03 18:02:34 +0000" MODIFIED_BY="[Empty name]">
<P>All randomised controlled trials involving achalasic participants given any type of nitrates were included.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2010-02-03 17:01:52 +0000" MODIFIED_BY="[Empty name]">
<P>Data were extracted by two independent observers.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2010-02-03 17:02:04 +0000" MODIFIED_BY="[Empty name]">
<P>Two randomised cross-over studies were found, but no results were included. Due to the design of the studies and the method of reporting the results in the original paper it was not possible to extract the necessary information to examine any of the outcomes.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2010-02-10 10:44:00 +0000" MODIFIED_BY="[Empty name]">
<P>From most of the single reports we found, after intake of nitrates (either nitroglycerin or isosorbide dinitrate), there was a fall in lower oesophageal pressure and improvement of radionuclide esophageal emptying compared to the baseline. From the available evidence, we cannot provide any implications for practice. Appropriately designed, parallel group, randomised controlled trials with long term follow-up are needed to determine the effects of nitrates for achalasia.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2010-02-24 10:29:13 +0000" MODIFIED_BY="Cathy Bennett">
<BACKGROUND MODIFIED="2010-02-24 10:29:13 +0000" MODIFIED_BY="Cathy Bennett">
<CONDITION MODIFIED="2010-02-10 10:45:05 +0000" MODIFIED_BY="[Empty name]">
<P>Achalasia is a disease that impairs oesophageal motility. This condition occurs when the lower oesophageal sphincter (LOS) fails to relax normally on swallowing. This results in food being retained above the constricted part of the oesophagus. The epidemiology of achalasia has not been extensively studied. The annual incidence has been estimated at 0.5 to 1.2 per 100,000 in Great Britain, Ireland, and the United States (<LINK REF="REF-Mayberry-1987" TYPE="REFERENCE">Mayberry 1987</LINK>; <LINK REF="REF-Mayberry-1985" TYPE="REFERENCE">Mayberry 1985</LINK>; <LINK REF="REF-Earlam-1969" TYPE="REFERENCE">Earlam 1969</LINK>; <LINK REF="REF-Howard-1992" TYPE="REFERENCE">Howard 1992</LINK>). It is seen in all races and in both sexes. The cause of this disease is unknown. Lower oesophageal sphincter relaxation is abnormal because the inhibitory nerves to the sphincter are either absent or functionally impaired. Symptoms of achalasia include dysphagia, regurgitation of food and retrosternal pain, which is increased when taking food. Oesophageal manometry, radiology (and, to a lesser extent, endoscopy) may help to establish a diagnosis and exclude other causes of esophageal obstruction. The oesophageal body usually is dilated and terminates in a narrowed segment. The classic manometric findings of achalasia are high resting pressure of LOS and low amplitude simultaneous contractions of the oesophageal body on deglutition.</P>
</CONDITION>
<INTERVENTION MODIFIED="2010-02-12 10:11:38 +0000" MODIFIED_BY="Cathy Bennett">
<P>All forms of interventions for achalasia are directed at relieving the obstruction, rather than providing a cure for the underlying causes of the disease. Pneumatic dilation of the lower esophageal sphincter under endoscopy is considered the definitive treatment for achalasia. Surgical myotomy, including the recently more preferred laparoscopic approach, provides the most effective and sustained clinical response, but given the related risks and complications of surgery, it is usually reserved for those for whom pneumatic balloon dilatations fails. Alternative medical interventions have certain advantages above those invasive methods, but their effect is controversial; usually offering only a mild, transient improvement. Such medical interventions include nitrates, calcium channel blockers and, recently, botulinum toxin. Nitrates and calcium channel blockers taken immediately before meals may somewhat relieve dysphagia. However, the long-term efficacy of these interventions is not known.</P>
</INTERVENTION>
<THEORY MODIFIED="2010-02-03 17:18:00 +0000" MODIFIED_BY="[Empty name]">
<P>Early in 1940s, there were reports of the use of nitroglycerin in achalasia (<LINK REF="REF-Ritvo-1940" TYPE="REFERENCE">Ritvo 1940</LINK>; <LINK REF="REF-Field-1944" TYPE="REFERENCE">Field 1944</LINK>). Since the mid-1970s, nitrates have been used widely as a vasodilator for cardiovascular diseases. Nitroglycerin and other nitrate-containing compounds activate guanylate cyclase, increasing the synthesis of cyclic GMP (guanosine 3', 5' monophosphate) in gastrointestinal smooth muscle (<LINK REF="REF-Katsuki-1977" TYPE="REFERENCE">Katsuki 1977</LINK>). The protein kinase produced by the interaction of guanylate cyclase with nitric acid alters the phosphorylation process in smooth muscle, resulting in dephosphorylation of the light chain of myosin and inhibition of the normal contractile process of smooth muscle. On the other hand, nitrate liberates nitric oxide (NO), which is an inhibitory non-adrenergic non-cholinergic (NANC) neurotransmitter mediated by cyclic GMP. Blocking the generation of NO was shown to inhibit the relaxation of the lower esophageal sphincter of animals (opossum, dog) and humans <I>in vitro</I> (<LINK REF="REF-Tottrup--1991" TYPE="REFERENCE">Tottrup 1991</LINK>). There are some reports that nitroglycerin provides symptomatic improvement for patients with oesophageal motility disorders by relaxing smooth muscle.</P>
</THEORY>
<IMPORTANCE MODIFIED="2010-02-24 10:29:13 +0000" MODIFIED_BY="Cathy Bennett">
<P>The effects of medical drugs are relatively mild in achalasia. Among the great variety of compounds have been tried, nitrates are probably the most effective drugs. However, most trials to date were not controlled and usually included a small number of patients.</P>
<P>Due to the relatively short half-life of nitrates, it is difficult to determine their long-term efficacy. However, if such medical interventions do provide benefits in the management of achalasia and delay the process of the disease, then they may be more acceptable to patients than the current endoscopic approaches.</P>
<P>Nitrates are usually dispensed in sublingual and tablet formulations. Sublingual therapy yields maximum plasma concentration in several minutes, but has a rapid fall-off. Sublingual therapy is advised for patients with achalasia because of the possibility of prolonged oesophageal transit and the resultant delayed gastric absorption. However, many patients prefer to take medication orally rather than sublingually.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2010-02-03 18:02:48 +0000" MODIFIED_BY="[Empty name]">
<P>To quantify short-term and long-term effects of nitrate treatment in participants with achalasia. Nitrates compared with any other types of intervention will be considered, this includes medical therapies, such as calcium-channel blockers, anticholinergic agents, beta-adrenergic agonists and botulinum toxin, endoscopic therapies, surgical therapies, placebo and no intervention.</P>
</OBJECTIVES>
<METHODS MODIFIED="2010-02-03 18:06:23 +0000" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2010-02-03 18:06:23 +0000" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2010-02-03 17:19:10 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trials with or without blinding. It was not necessary for the control group to receive a placebo.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2010-02-03 18:06:10 +0000" MODIFIED_BY="[Empty name]">
<P>Participants with achalasia as diagnosed by symptoms and radiology or manometric findings of the oesophagus are included. Cardiac carcinoma and achalasia of Chagas' disease were excluded.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2010-02-03 17:20:12 +0000" MODIFIED_BY="[Empty name]">
<P>The drug therapies reviewed are: </P>
<UL>
<LI>isosorbide dinitrate</LI>
<LI>nitroglycerin (glyceryl trinitrate)</LI>
<LI>pentaerythrital</LI>
<LI>amyl nitrite</LI>
<LI>octyl nitrite</LI>
</UL>
<P>All taken orally or sublingually or transdermally.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2010-02-03 18:06:23 +0000" MODIFIED_BY="[Empty name]">
<P>
<BR/>
</P>
<CRIT_OUTCOMES_PRIMARY MODIFIED="2010-02-03 18:06:23 +0000" MODIFIED_BY="[Empty name]">
<OL>
<LI>Occurrence of invasive procedure (that is, whether a participant still required treatment by invasive procedures including dilatation and surgery).</LI>
</OL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2010-02-03 17:55:23 +0000" MODIFIED_BY="[Empty name]">
<OL>
<LI>Improvement of symptoms (e.g. dysphagia, regurgitation of food, retrosternal pain).</LI>
<LI>Reduction of LOS pressure.</LI>
<LI>Oesophageal emptying rate.</LI>
<LI>Side effects: headache, flush, change of blood pressure.</LI>
</OL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2010-02-03 17:55:29 +0000" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2010-02-03 17:55:29 +0000" MODIFIED_BY="[Empty name]">
<P>Trials were identified by searching the Cochrane Controlled Trials Register (Issue 4-2001), MEDLINE (1966-2001), EMBASE (1980-2001), LILACS - Latin American and Caribbean health science literature (1982-2001) and CBM-Chinese Biomedical database(1980-2000). Additionally, all references in the identified trials were checked for further relevant trials. An updated search was run on the Cochrane Library, MEDLINE, and EMBASE in September 2003, October 2004, September 2005 and December 2008.<BR/>
<BR/>The Cochrane Highly Sensitive Search Strategy for identifying randomised trials in MEDLINE, Sensitivity maximising version, Ovid format (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>), was combined with the search terms in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> to identify randomised controlled trials in MEDLINE. The MEDLINE search strategy was adapted for use in the other databases searched.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2009-04-10 13:48:11 +0100" MODIFIED_BY="Cathy Bennett">
<P>Reference lists from trials selected by electronic searching were handsearched to identify further relevant trials.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2010-02-03 17:25:21 +0000" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2009-04-10 13:50:40 +0100" MODIFIED_BY="Cathy Bennett">
<P>Titles and abstracts identified for possible inclusion in the review were checked by two reviewers. The full text of all studies of possible relevance was obtained for independent assessment by both reviewers. The reviewers decided which trials fit the inclusion criteria, and graded the methodological quality of the studies. Any disagreement was resolved by discussion between the reviewers and consultation with the third reviewer.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2010-02-03 17:21:29 +0000" MODIFIED_BY="[Empty name]">
<P>Data extraction was performed by a single reviewer and checked by a second reviewer.<BR/>
</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2010-02-03 17:22:13 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Methodological quality of included studies</HEADING>
<P>The methodological quality of the included trials was assessed with particular emphasis on the allocation concealment, which was ranked using the Cochrane approach:<BR/>Grade A: Adequate concealment,<BR/>Grade B: Uncertain,<BR/>Grade C: Clearly inadequate concealment.</P>
<P>The methodological quality of studies was also be documented using the following criteria:</P>
<UL>
<LI>baseline comparison of experimental groups,</LI>
<LI>explicit diagnostic criteria,</LI>
<LI>completeness of follow-up,</LI>
<LI>blind outcome assessment and</LI>
<LI>blind administration of nitrates.</LI>
</UL>
</SUBSECTION>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2010-02-03 17:15:15 +0000" MODIFIED_BY="[Empty name]">
<P>Data were extracted based on the intention to treat principle. Odds ratios for incidence of invasive procedure, improvement of symptoms, LOS pressure decrease, oesophageal emptying, and side effects were calculated. Numbers needed to treat (NNT) for avoiding invasive procedure, improvement of symptoms, oesophageal emptying, and numbers needed to harm (NNH) of side effects were also determined. 95% confidence intervals (CI) were calculated for all outcomes.</P>
</EFFECT_MEASURES>
<DATA_SYNTHESIS MODIFIED="2010-02-03 17:25:21 +0000" MODIFIED_BY="[Empty name]">
<P>No meta-analysis was possible. We had intended to use the following methods to pool data. For dichotomous outcomes, such as incidence of invasive procedure, improvement of symptoms, the fixed-effect Mantel-Haenszel odds ratio would have been used. For continuous outcomes, such as LOS pressure decrease, oesophageal emptying, the fixed-effect mean difference would have been used.</P>
</DATA_SYNTHESIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2010-02-10 11:42:40 +0000" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2010-02-10 11:42:40 +0000" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2010-02-03 17:26:43 +0000" MODIFIED_BY="[Empty name]">
<P>Twenty-seven references were considered during eligibility assessments as potential randomised controlled trials which fit the inclusion criteria, and were reviewed.<BR/>
</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2010-02-10 11:41:55 +0000" MODIFIED_BY="[Empty name]">
<P>Two trials were identified that satisfied the inclusion criteria (see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>).</P>
<P>In both studies participants received all interventions in a random order (<LINK REF="STD-Gelfond-1982" TYPE="STUDY">Gelfond 1982</LINK>; <LINK REF="STD-Wong-1987" TYPE="STUDY">Wong 1987</LINK>). In one study (<LINK REF="STD-Gelfond-1982" TYPE="STUDY">Gelfond 1982</LINK>), fifteen participants received isosorbide dinitrate (5mg) and nifedipine (20mg). Each participant received each intervention for "at least one week", it was unclear how long each participant received each intervention for or what order the interventions were received in. In the other study (<LINK REF="STD-Wong-1987" TYPE="STUDY">Wong 1987</LINK>), fifteen participants received nitroglycerin (0.4mg s.l), normal saline (0.25ml s.c.), terbutaline sulfate (0.25 mg s.c.) and aminophylline (5.0 mg kg-1). Each participant received one dose of each intervention on four separate days, it was unclear what the time span was in between each intervention. The order in which participants received interventions in was not given in the paper.</P>
<P>Neither study had an appropriate design for measuring the invasive procedure rate or long term effects. In <LINK REF="STD-Gelfond-1982" TYPE="STUDY">Gelfond 1982</LINK>, the symptom relief was assessed subjectively by the physician. LOS pressure was reported at five minute intervals after initial intervention, oesophageal emptying and side effects were measured at the end of each intervention phase. It was unclear how often readings of oesophageal emptying were taken, but measurements were started ten minutes after isosorbide dinitrate administration and 30 minutes after nifedipine administration. In <LINK REF="STD-Wong-1987" TYPE="STUDY">Wong 1987</LINK>, LOS pressure was measured after intervention but after different timings for each intervention (10, 20, 30, 45 and 60 minutes after terbutaline sulfate and saline; five, 10, 20 and 30 min after nitroglycerin; and immediately, 10, 20, 30, 45 minutes after aminophylline) and esophogeal emptying rate was only measured for participants that responded to the intervention.</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2010-02-10 11:42:40 +0000" MODIFIED_BY="[Empty name]">
<P>Twenty-five studies were excluded (see <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>), 21 (77.8%) were studies that did not compare nitrates and four (14.8%) were non-randomised comparisons of nitrates. Of the non-randomised studies, two were before and after studies (<LINK REF="STD-Gelfond-1981" TYPE="STUDY">Gelfond 1981</LINK>; <LINK REF="STD-Wang-1988" TYPE="STUDY">Wang 1988</LINK>), one a non-randomised study comparing nifedipine (nine participants) to isosorbide dinitrate (seven participants) (<LINK REF="STD-Bortolotti-1994" TYPE="STUDY">Bortolotti 1994</LINK>), and one compared amyl nitrate with glyceryl trinitrate (seven participants) and with Mercury bougie (five participants) (<LINK REF="STD-Douthwaite-1943" TYPE="STUDY">Douthwaite 1943</LINK>).</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2010-02-03 18:03:11 +0000" MODIFIED_BY="[Empty name]">
<P>Please see the risk of bias tables in the '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>' table.</P>
<P>Neither of the two included studies (<LINK REF="STD-Gelfond-1982" TYPE="STUDY">Gelfond 1982</LINK>; <LINK REF="STD-Wong-1987" TYPE="STUDY">Wong 1987</LINK>) mentioned method of randomisation or allocation concealment, nor was it clear whether the participants were blind to their allocation, but both studies mentioned that the assessor of LOS was blind.<BR/>Both studies had explicit diagnostic criteria; <LINK REF="STD-Gelfond-1982" TYPE="STUDY">Gelfond 1982</LINK> reported the number of marked dilated oesophagus in the group, indicate the severity of the group. This study also had a follow-up of 8-14 months, but this is not relevant for a study with repeated interventions. Both studies took baseline assessments, but comparability between groups was not relevant because of the differences in the design of the studies.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2010-02-03 18:09:09 +0000" MODIFIED_BY="[Empty name]">
<P>It was not possible to distinguish the randomised groups in either study, the results presented per intervention were for all participants regardless of the order the interventions were received in. Meta analysis was not possible. The trial investigators were contacted to obtain this information. Unfortunately, Professor Gelfond died several years ago. His colleague, who worked with him on the same research study, could not provide further materials of the results of this, which was published in 1982. To date we have received no response from the authors of <LINK REF="STD-Wong-1987" TYPE="STUDY">Wong 1987</LINK>.<BR/>
<BR/>It was not possible to present the results from each study separately. The analyses that the studies presented for LOS pressure were comparisons of each intervention to baseline, no comparison between interventions was done and no within participant information was available. In <LINK REF="STD-Gelfond-1982" TYPE="STUDY">Gelfond 1982</LINK>, although data on oesophageal emptying, symptom relief and side effects were given for each participant, making it possible to make a comparison between interventions, we have not made this comparison because there was no pre-defined duration for a phase, and it was not clear what determined the duration of intervention for each participant.</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2010-02-12 10:10:26 +0000" MODIFIED_BY="Cathy Bennett">
<P>Only two randomised studies were found which compared nitrate to alternate intervention for achalasia. The designs and reporting methods of these were not appropriate for meta analysis. In both studies, participants received all interventions in a random order. The primary outcome (occurrence of invasive procedure) cannot be considered when participants receive all interventions. One study (<LINK REF="STD-Wong-1987" TYPE="STUDY">Wong 1987</LINK>) looked only at the short-term outcomes. The other study (<LINK REF="STD-Gelfond-1982" TYPE="STUDY">Gelfond 1982</LINK>) did look at longer term effects, but it was unclear what the duration of intervention was or what determined this. Appropriately designed parallel group randomised controlled trials with long term follow up are needed to confirm the effect of nitrates for achalasia.</P>
<P>Since this review was first written, newer therapies have to some extent superceded the use of nitrates and other oral medications (calcium channel blockers) as treatments for achalasia (<LINK REF="STD-Vaezi-1998" TYPE="STUDY">Vaezi 1998</LINK>). Nitrates can still be used in patients with mild symptoms, in cases where the patient is not a suitable candidate for surgery for, or when treatment of mild disease does not warrant the use of an invasive procedure. Nitrates can also be used if there is no response to injections of botulinum toxin to relax the oesophagus. One other widely used option for the treatment of achalasia is endoscopic pneumatic dilation of the oesophagus. This review found there is not enough evidence from trials to show if nitrates are an effective treatment to relieve achalasia.</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2010-02-03 17:53:58 +0000" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2010-02-03 17:53:58 +0000" MODIFIED_BY="[Empty name]">
<P>We found no suitable randomised controlled trials and therefore cannot make any recommendations for practice. Although non-randomised trials have found evidence that nitrates relieve symptoms of achalasia and promote some measurements (<LINK REF="STD-Gelfond-1981" TYPE="STUDY">Gelfond 1981</LINK>; <LINK REF="STD-Wang-1988" TYPE="STUDY">Wang 1988</LINK>; <LINK REF="STD-Bortolotti-1994" TYPE="STUDY">Bortolotti 1994</LINK>; <LINK REF="STD-Douthwaite-1943" TYPE="STUDY">Douthwaite 1943</LINK>), evidence of side effects such as flush, headache and blood pressure change have also been reported (<LINK REF="STD-Douthwaite-1943" TYPE="STUDY">Douthwaite 1943</LINK>; <LINK REF="STD-Gelfond-1981" TYPE="STUDY">Gelfond 1981</LINK>; <LINK REF="STD-Gelfond-1982" TYPE="STUDY">Gelfond 1982</LINK>; <LINK REF="STD-Rozen-1982a" TYPE="STUDY">Rozen 1982a</LINK>; <LINK REF="STD-Bassotti-1988" TYPE="STUDY">Bassotti 1988</LINK>). We therefore suggest that nitrates should only be used as an intervention in randomised trials, until further evidence has been found.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2010-02-03 17:53:42 +0000" MODIFIED_BY="[Empty name]">
<P>There are no placebo-controlled randomised trials and only two randomised cross-over controlled trials. More randomised controlled trial data would be needed to determine the effects of nitrates. Many clinical trials we investigated only reported the acute effect of nitrate, that is the effects seen within an hour. Data on patient outcomes when nitrates are used for symptom relief are still lacking. The results of one retrospective study indicated that elderly patients with achalasia responded more poorly to nitrate than the younger patients; prospective studies are needed to confirm this (<LINK REF="STD-Ghosh-1994" TYPE="STUDY">Ghosh 1994</LINK>). The long term effects of nitrates, when given continuously, should be investigated, such as recording patients' responses at one month or one year.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2010-02-03 17:16:19 +0000" MODIFIED_BY="[Empty name]">
<P>We thank Janet Lilleyman, Cathy Bennett, and Iris Gordon, of the Cochrane Upper Gastrointestinal and Pancreatic Group, for their invaluable help throughout the review and the update. We are most grateful to them for their advice and support.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2010-02-03 17:16:23 +0000" MODIFIED_BY="[Empty name]">
<P>None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2010-02-12 10:11:18 +0000" MODIFIED_BY="Cathy Bennett">
<P>All authors contributed to development of the protocol, writing the review and subsequent updates.</P>
<P>ZW composed the protocol and the review. GE described the included and excluded studies and contributed to communications with trial investigators. YW supervised the work.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2010-02-03 17:32:57 +0000" MODIFIED_BY="[Empty name]">
<P>At the update in 2010, we added change in blood pressure (a side effect) to the list of outcomes.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES MODIFIED="2010-02-03 18:47:32 +0000" MODIFIED_BY="[Empty name]">
<P>Searches, tables and figures last updated February 2010. Declared stable and no future updates planned.</P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2010-02-10 20:48:30 +0000" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2010-02-10 11:52:11 +0000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2010-02-03 11:34:38 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Gelfond-1982" MODIFIED="2010-02-03 11:34:31 +0000" MODIFIED_BY="[Empty name]" NAME="Gelfond 1982" YEAR="1982">
<REFERENCE NOTES="&lt;p&gt;9. Gelfond, M.; Rozen, P., and Gilat, T. Isosorbide dinitrate and nifedipine treatment of achalasia: a clinical, manometric and radionuclide evaluation. Gastroenterology. 1982 Nov; 83(5):963-9; ISSN: 0016-5085.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Gelfond M, Rozen P, Gilat T</AU>
<TI>Isosorbide dinitrate and nifedipine treatment of achalasia: a clinical, manometric and radionuclide evaluation</TI>
<SO>Gastroenterology</SO>
<YR>1982</YR>
<VL>83</VL>
<NO>5</NO>
<PG>963-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="ISSN: 0016-5085"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wong-1987" MODIFIED="2010-02-03 11:34:38 +0000" MODIFIED_BY="[Empty name]" NAME="Wong 1987" YEAR="1987">
<REFERENCE NOTES="&lt;p&gt;27. Wong, R. K.H.; Maydonovitch, C.; Garcia, J. E.; Johnson, L. F., and Castell, D. O. The effect of terbutaline sulfate, nitroglycerin, and aminophylline on lower esophageal sphincter pressure and radionuclide esophageal emptying in patients with achalasia. Journal of Clinical Gastroenterology. 1987 Aug; 9(4):386-9; ISSN: 0192-0790.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wong RKH, Maydonovitch C, Garcia JE, Johnson LF, Castell DO</AU>
<TI>The effect of terbutaline sulfate, nitroglycerin, and aminophylline on lower esophageal sphincter pressure and radionuclide esophageal emptying in patients with achalasia</TI>
<SO>Journal of Clinical Gastroenterology</SO>
<YR>1987</YR>
<VL>9</VL>
<NO>4</NO>
<PG>386-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="0192-0790"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2010-02-10 11:52:11 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Achkar-1995" MODIFIED="2010-02-03 18:15:32 +0000" MODIFIED_BY="[Empty name]" NAME="Achkar 1995" YEAR="1995">
<REFERENCE MODIFIED="2010-02-03 18:15:32 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Achkar, E</AU>
<TI>Achalasia</TI>
<SO>Gastroenterologist.</SO>
<YR>1995</YR>
<VL>3</VL>
<NO>4</NO>
<PG>273-88</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Allescher-1993" MODIFIED="2010-02-03 18:15:48 +0000" MODIFIED_BY="[Empty name]" NAME="Allescher 1993" YEAR="1993">
<REFERENCE MODIFIED="2010-02-03 18:15:48 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Allescher HD, Ravich WJ</AU>
<TI>Medical treatment of esophageal motility disorders</TI>
<SO>Dysphagia</SO>
<YR>1993</YR>
<VL>8</VL>
<NO>2</NO>
<PG>125-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bassotti-1988" MODIFIED="2010-02-10 11:48:52 +0000" MODIFIED_BY="[Empty name]" NAME="Bassotti 1988" YEAR="1988">
<REFERENCE MODIFIED="2010-02-10 11:48:52 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bassotti G, Gaburri M, Bucaneve G, Farroni F, Pelli MA, Morelli A</AU>
<TI>Effects of transdermal nitroglycerin on manometric and clinical parameters in patients with achalasia of the esophagus</TI>
<SO>Current Therapeutic Research</SO>
<YR>1988</YR>
<VL>44</VL>
<NO>3</NO>
<PG>391-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bassotti-1999" MODIFIED="2010-02-03 11:35:05 +0000" MODIFIED_BY="[Empty name]" NAME="Bassotti 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bassotti G, Annese V</AU>
<TI>Review article: pharmacological options in achalasia</TI>
<SO>Alimentary Pharmacology &amp; Therapeutics.</SO>
<YR>1999</YR>
<VL>13</VL>
<NO>11</NO>
<PG>1391-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bortolotti-1994" MODIFIED="2010-02-03 11:35:11 +0000" MODIFIED_BY="[Empty name]" NAME="Bortolotti 1994" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;4. Bortolotti, M.; Coccia, G.; Brunelli, F.; Sarti, P.; Mazza, M.; Bagnato, F., and Barbara, L. Isosorbide dinitrate or nifedipine: which is preferable in the medical therapy of achalasia?. Italian Journal of Gastroenterology. 1994 Oct-1994 Nov 30; 26(8):379-82; ISSN: 0392-0623.ON ORDER&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bortolotti M, Coccia G, Brunelli F, Sarti P, Mazza M, Bagnato F, Barbara L</AU>
<TI>Isosorbide dinitrate or nifedipine: which is preferable in the medical therapy of achalasia?</TI>
<SO>Italian Journal of Gastroenterology.</SO>
<YR>1994</YR>
<VL>26</VL>
<PG>379-82</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="0392-0623"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bourgeois-1992" MODIFIED="2010-02-10 11:49:16 +0000" MODIFIED_BY="[Empty name]" NAME="Bourgeois 1992" YEAR="1992">
<REFERENCE MODIFIED="2010-02-10 11:49:16 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;5. Bourgeois, N.; Coffernils, M.; Sznajer, Y.; Panzer, J. M.; Gelin, M., and Cremer, M. Non-surgical management of achalasia. Acta Gastroenterologica Belgica. 1992 May-1992 Jun 30; 55(3):260-3; ISSN: 0001-5644.&lt;/p&gt;" NOTES_MODIFIED="2010-02-10 11:49:16 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bourgeois N, Coffernils M, Sznajer Y, Panzer JM, Gelin M, Cremer M</AU>
<TI>Non-surgical management of achalasia</TI>
<SO>Acta Gastroenterologica Belgica</SO>
<YR>1992</YR>
<VL>55</VL>
<NO>3</NO>
<PG>260-3</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="ISSN: 0001-5644"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Douthwaite-1943" MODIFIED="2010-02-10 11:49:37 +0000" MODIFIED_BY="[Empty name]" NAME="Douthwaite 1943" YEAR="1943">
<REFERENCE MODIFIED="2010-02-10 11:49:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Douthwaite AH</AU>
<TI>Achalasia of cardia. Treatment with nitrites</TI>
<SO>Lancet</SO>
<YR>1943</YR>
<VL>2</VL>
<PG>353-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2010-01-26 03:25:22 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="OTHER" VALUE=""/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Efrati-1996" MODIFIED="2010-02-03 11:36:39 +0000" MODIFIED_BY="[Empty name]" NAME="Efrati 1996" YEAR="1996">
<REFERENCE NOTES="&lt;p&gt;6. Efrati, Y.; Horne, T.; Livshitz, G.; Broide, E.; Klin, B., and Vinograd, I. Radionuclide esophageal emptying and long-acting nitrates (Nitroderm) in childhood achalasia. Journal of Pediatric Gastroenterology &amp;amp; Nutrition. 1996 Oct; 23(3):312-5; ISSN: 0277-2116.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Efrati Y, Horne T, Livshitz G, Broide E, Klin B, Vinograd I</AU>
<TI>Radionuclide esophageal emptying and long-acting nitrates (Nitroderm) in childhood achalasia</TI>
<SO>Journal of Pediatric Gastroenterology &amp; Nutrition</SO>
<YR>1996</YR>
<VL>23</VL>
<NO>3</NO>
<PG>312-5</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="0277-2116"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ferguson-1981" MODIFIED="2010-02-10 11:49:51 +0000" MODIFIED_BY="[Empty name]" NAME="Ferguson 1981" YEAR="1981">
<REFERENCE MODIFIED="2010-02-10 11:49:51 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;7. Ferguson, S. C.; Hodges, K.; Hersh, T., and Jinich, H. Esophageal Manometry in Patients with Chest Pain and Normal Coronary Arteriogram. American Journal of Gastroenterology. 1981 Feb; 75(2):124-7; ISSN: 0002-9270.&lt;/p&gt;" NOTES_MODIFIED="2010-02-10 11:49:51 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ferguson SC, Hodges K, Hersh T, Jinich H</AU>
<TI>Esophageal manometry in patients with chest pain and normal coronary arteriogram</TI>
<SO>American Journal Gastroenterology</SO>
<YR>1981</YR>
<VL>75</VL>
<NO>2</NO>
<PG>124-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="ISSN: 0002-9270."/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Furuya-1995" MODIFIED="2010-02-03 18:16:15 +0000" MODIFIED_BY="[Empty name]" NAME="Furuya 1995" YEAR="1995">
<REFERENCE MODIFIED="2010-02-03 18:16:15 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;8. Furuya, R.; Kunimi, M.; Ihara, F.; Ishihara, M.; Mori, K.; Yoshiya, K.; Sakakibara, K.; Iida, K.; Nishino, M., and Yoshitoshi, K. [A case of vigorous achalasia, successfully treated with isosorbide dinitrate spray]. [Japanese]. Nippon Shokakibyo Gakkai Zasshi - Japanese Journal of Gastroenterology. 1995 Oct; 92(10):1765-9; ISSN: 0446-6586.ON ORDER y&lt;/p&gt;" NOTES_MODIFIED="2010-02-03 18:16:15 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Furuya R, Kunimi M, Ihara F, Ishihara M, Mori K, Yoshiya K et al</AU>
<TI>A case of vigorous achalasia, successfully treated with isosorbide dinitrate spray</TI>
<SO>Nippon Shokakibyo Gakkai Zasshi - Japanese Journal of Gastroenterology.</SO>
<YR>1995</YR>
<VL>92</VL>
<NO>10</NO>
<PG>1765-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="0446-6586"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gelfond-1981" MODIFIED="2010-02-03 11:36:56 +0000" MODIFIED_BY="[Empty name]" NAME="Gelfond 1981" YEAR="1981">
<REFERENCE NOTES="&lt;p&gt;10. Gelfond, M.; Rozen, P.; Keren, S., and Gilat, T. Effect of nitrates on LOS pressure in achalasia: a potential therapeutic aid. Gut. 1981 Apr; 22(4):312-8; ISSN: 0017-5749.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Gelfond M, Rozen P, Keren S, Gilat T</AU>
<TI>Effect of nitrates on LOS pressure in achalasia: a potential therapeutic aid</TI>
<SO>Gut</SO>
<YR>1981</YR>
<VL>22</VL>
<NO>4</NO>
<PG>312-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="0017-5749"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ghosh-1994" MODIFIED="2010-02-03 11:37:04 +0000" MODIFIED_BY="[Empty name]" NAME="Ghosh 1994" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;11. Ghosh, S.; Heading, R. C., and Palmer, K. R. Achalasia of the oesophagus in elderly patients responds poorly to conservative therapy. Age &amp;amp; Ageing. 1994 Jul; 23(4):280-2; ISSN: 0002-0729.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Ghosh S, Heading RC, Palmer KR</AU>
<TI>Achalasia of the oesophagus in elderly patients responds poorly to conservative therapy</TI>
<SO>Age &amp; Ageing</SO>
<YR>1994</YR>
<VL>23</VL>
<NO>4</NO>
<PG>280-2</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="0002-0729"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hildebrand-1993" MODIFIED="2010-02-03 11:37:10 +0000" MODIFIED_BY="[Empty name]" NAME="Hildebrand 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hildebrand T, Podracky J, Zakuciova M</AU>
<TI>[Diagnosis and therapy of esophageal diseases]</TI>
<SO>Vnitrni Lekarstvi</SO>
<YR>1993</YR>
<VL>39</VL>
<NO>2</NO>
<PG>132-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kikendall-1980" MODIFIED="2010-02-03 11:37:17 +0000" MODIFIED_BY="[Empty name]" NAME="Kikendall 1980" YEAR="1980">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kikendall JW, Mellow MH</AU>
<TI>Effect of sublingual nitroglycerin and long-acting nitrate preparations on esophageal motility</TI>
<SO>Gastroenterology</SO>
<YR>1980</YR>
<VL>79</VL>
<PG>703-706</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Krivchenya-1990" MODIFIED="2010-02-03 11:37:23 +0000" MODIFIED_BY="[Empty name]" NAME="Krivchenya 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;13. Krivchenia, D. I. u.; Almashii, G. G.; Iurchenko, N. I.; Dubrovin, A. G.; Brusilovskaia, G. A., and Palkina, I. S. [Diagnosis and treatment of esophageal achalasia in children]. [Russian]. Grudnaia i Serdechno-Sosudistaia Khirurgiia. 1990; (3):45-8; ISSN: 0236-2791.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Krivchenya D; Almashii GG, Yurchenko NI, Dubrovin AG, Brusilovskaya GA, Palkina IS</AU>
<TI>Diagnosis and treatment of esophageal achalasia in children</TI>
<SO>Grudnaia i Serdechno-Sosudistaia Khirurgiia.</SO>
<YR>1990</YR>
<VL>3</VL>
<PG>45-48</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ona-1980" MODIFIED="2010-02-03 18:22:38 +0000" MODIFIED_BY="[Empty name]" NAME="Ona 1980" YEAR="1980">
<REFERENCE MODIFIED="2010-02-03 18:22:38 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Ona, F. V. and Polintan, L. S. Vigorous achalasia. Manometric response to atropine and nitroglycerin. Archives of Internal Medicine. 1980 Aug; 140(8):1118-20; ISSN: 0003-9926.&lt;/p&gt;" NOTES_MODIFIED="2010-02-03 18:22:38 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ona FV, Polintan LS</AU>
<TI>Vigorous achalasia manometric response to atropine and nitroglycerin</TI>
<SO>Archives of Internal Medicine</SO>
<YR>1980</YR>
<VL>140</VL>
<NO>8</NO>
<PG>1118-1120</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="ISSN: 0003-9926."/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reynolds-1989" MODIFIED="2010-02-03 11:37:40 +0000" MODIFIED_BY="[Empty name]" NAME="Reynolds 1989" YEAR="1989">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reynolds JC, Parkman HP</AU>
<TI>Achalasia</TI>
<SO>Gastroenterology Clinics of North America.</SO>
<YR>1989</YR>
<VL>18</VL>
<NO>2</NO>
<PG>223-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rozen-1982a" MODIFIED="2010-02-03 11:37:48 +0000" MODIFIED_BY="[Empty name]" NAME="Rozen 1982a" YEAR="1982">
<REFERENCE NOTES="&lt;p&gt;18. Rozen, P.; Gelfond, M.; Zaltzman, S.; Baron, J., and Gilat, T. Dynamic, diagnostic, and pharmacological radionuclide studies of the esophagus in achalasia. Radiology. 1982 Aug; 144(3):587-90; ISSN: 0033-8419.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Rozen P, Gelfond M, Zaltzman S, Baron J, Gilat T</AU>
<TI>Dynamic, diagnostic, and pharmacological radionuclide studies of the esophagus in achalasia</TI>
<SO>Radiology</SO>
<YR>1982</YR>
<VL>144</VL>
<NO>3</NO>
<PG>587-590</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="0033-8419"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rozen-1982b" MODIFIED="2010-02-03 11:37:56 +0000" MODIFIED_BY="[Empty name]" NAME="Rozen 1982b" YEAR="1982">
<REFERENCE NOTES="&lt;p&gt;17. Rozen, P.; Gelfond, M.; Salzman, S.; Baron, J., and Gilat, T. Radionuclide confirmation of the therapeutic value of isosorbide dinitrate in relieving the dysphagia in achalasia. Journal of Clinical Gastroenterology. 1982 Feb; 4(1):17-22; ISSN: 0192-0790.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Rozen P, Gelfond M, Salzman S, Baron J, Gilat T</AU>
<TI>Radionuclide confirmation of the therapeutic value of isosorbide dinitrate in relieving the dysphagia in achalasia</TI>
<SO>Journal of Clinical Gastroenterology</SO>
<YR>1982</YR>
<VL>4</VL>
<NO>1</NO>
<PG>17-22</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="0192-0790"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schroeder-1985" MODIFIED="2010-02-03 11:38:01 +0000" MODIFIED_BY="[Empty name]" NAME="Schroeder 1985" YEAR="1985">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schroeder JS</AU>
<TI>Combination therapy with isosorbide dinitrate: current status and the future</TI>
<SO>American Heart Journal.</SO>
<YR>1985</YR>
<VL>110</VL>
<NO>1 Pt 2</NO>
<PG>284-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stanley-1955" MODIFIED="2010-02-03 11:38:07 +0000" MODIFIED_BY="[Empty name]" NAME="Stanley 1955" YEAR="1955">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Stanley H, Lorber SM, Shay H</AU>
<TI>Roentgen studies of esophageal transport in patients with dysphagia due to abnormal motor function</TI>
<SO>Gastroenterology</SO>
<YR>1955</YR>
<VL>28</VL>
<PG>697-714</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Storr-1999" MODIFIED="2010-02-03 11:38:12 +0000" MODIFIED_BY="[Empty name]" NAME="Storr 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Storr M, Allescher HD</AU>
<TI>Esophageal pharmacology and treatment of primary motility disorders</TI>
<SO>Diseases of the Esophagus.</SO>
<YR>1999</YR>
<VL>12</VL>
<NO>4</NO>
<PG>241-57</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Swamy-1977" MODIFIED="2010-02-10 11:52:11 +0000" MODIFIED_BY="[Empty name]" NAME="Swamy 1977" YEAR="1977">
<REFERENCE MODIFIED="2010-02-10 11:52:11 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Swamy, N. Esophageal spasm: clinical and manometric response to nitroglycerine and long acting nitrites. Gastroenterology. 1977 Jan; 72(1):23-7; ISSN: 0016-5085.&lt;/p&gt;" NOTES_MODIFIED="2010-02-10 11:52:11 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Swamy N</AU>
<TI>Esophageal spasm: clinical and manometric response to nitroglycerine and long acting nitrites</TI>
<SO>Gastroenterology</SO>
<YR>1977</YR>
<VL>72</VL>
<NO>1</NO>
<PG>23-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="ISSN: 0016-5085"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tack-1991" MODIFIED="2010-02-03 11:38:22 +0000" MODIFIED_BY="[Empty name]" NAME="Tack 1991" YEAR="1991">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tack J, Janssens J, Vantrappen G</AU>
<TI>Non-surgical treatment of achalasia</TI>
<SO>Hepato-Gastroenterology.</SO>
<YR>1991</YR>
<VL>38</VL>
<NO>6</NO>
<PG>493-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Traube-1985" MODIFIED="2010-02-03 11:38:28 +0000" MODIFIED_BY="[Empty name]" NAME="Traube 1985" YEAR="1985">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Traube M, McCallum RW</AU>
<TI>Primary oesophageal motility disorders. Current therapeutic concepts</TI>
<SO>Drugs</SO>
<YR>1985</YR>
<VL>30</VL>
<NO>1</NO>
<PG>66-77</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vaezi-1998" MODIFIED="2010-02-03 18:17:33 +0000" MODIFIED_BY="[Empty name]" NAME="Vaezi 1998" YEAR="1998">
<REFERENCE MODIFIED="2010-02-03 18:17:33 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vaezi MF, Richter JE</AU>
<TI>Achalasia: diagnosis and management</TI>
<SO>Seminars in Gastrointestinal Disease</SO>
<YR>1999</YR>
<VL>10</VL>
<NO>3</NO>
<PG>103-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-1988" MODIFIED="2010-02-03 18:21:34 +0000" MODIFIED_BY="[Empty name]" NAME="Wang 1988" YEAR="1988">
<REFERENCE MODIFIED="2010-02-03 18:21:34 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;26. Wang, S. Y. [Radionuclide esophagography observation on the effect of nitrates in achalasia of the cardia]. [Chinese]. Chung-Hua i Hsueh Tsa Chih [Chinese Medical Journal]. 1988 Jul; 68(7):378-9; ISSN: 0376-2491.&lt;/p&gt;" NOTES_MODIFIED="2010-02-03 18:21:34 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Wang SY, Wu TY, Dai XZ, Wang G, Zhu GH</AU>
<TI>[Radionuclide esophagography observation on the effect of nitrates in achalasia of the cardia]</TI>
<SO>Chung-Hua i Hsueh Tsa Chih [Chinese Medical Journal]</SO>
<YR>1988</YR>
<VL>68</VL>
<NO>7</NO>
<PG>378-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="0376-2491"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2010-02-10 20:48:30 +0000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2010-02-10 20:48:30 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Earlam-1969" MODIFIED="2010-02-10 11:53:27 +0000" MODIFIED_BY="[Empty name]" NAME="Earlam 1969" TYPE="JOURNAL_ARTICLE">
<AU>Earlam RJ, Ellis FH Jr, Nobrega FT</AU>
<TI>Achalasia of the esophagus in a small urban community</TI>
<SO>Mayo Clinic Proceedings</SO>
<YR>1969</YR>
<VL>44</VL>
<PG>478-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Field-1944" MODIFIED="2010-02-10 11:52:48 +0000" MODIFIED_BY="[Empty name]" NAME="Field 1944" TYPE="JOURNAL_ARTICLE">
<AU>Field CE, Lond MD</AU>
<TI>Octyl Nitrate in Achalasia of the Cardia</TI>
<SO>Lancet</SO>
<YR>1944</YR>
<VL>2</VL>
<PG>848-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2008" MODIFIED="2010-02-03 18:23:54 +0000" MODIFIED_BY="[Empty name]" NAME="Higgins 2008" TYPE="BOOK">
<AU>Higgins JPT, Green S (editors)</AU>
<SO>Cochrane handbook for systematic reviews of interventions</SO>
<YR>2008</YR>
<PB>John Wiley &amp; Sons Ltd</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Howard-1992" MODIFIED="2010-02-10 11:53:44 +0000" MODIFIED_BY="[Empty name]" NAME="Howard 1992" TYPE="JOURNAL_ARTICLE">
<AU>Howard PJ. Maher L, Pryde A, et al</AU>
<TI>Five year prospective study of the incidence, clinical features, and diagnosis of achalasia in Edinburgh</TI>
<SO>Gut</SO>
<YR>1992</YR>
<VL>33</VL>
<PG>1011-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Katsuki-1977" MODIFIED="2010-02-03 18:18:15 +0000" MODIFIED_BY="[Empty name]" NAME="Katsuki 1977" TYPE="JOURNAL_ARTICLE">
<AU>Katsuki S, Arnold W, Mittal C, Murad F</AU>
<TI>Stimulation of guanylase cyclase by sodium nitroprusside, nitroglycerin, and nitric oxide in various tissue preparations and comparison to the effects of Na azide and hydroxylamine</TI>
<SO>Journal of Cyclic Nucleotide Research</SO>
<YR>1977</YR>
<VL>3</VL>
<PG>23-35</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mayberry-1985" MODIFIED="2010-02-03 18:18:48 +0000" MODIFIED_BY="[Empty name]" NAME="Mayberry 1985" TYPE="JOURNAL_ARTICLE">
<AU>Mayberry JF, Atkinson M</AU>
<TI>Studies of incidence and prevalence of achalasia in the Nottingham area</TI>
<SO>Quarterly Journal of Medicine</SO>
<YR>1985</YR>
<VL>56</VL>
<PG>451-456</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mayberry-1987" MODIFIED="2010-02-03 18:21:08 +0000" MODIFIED_BY="[Empty name]" NAME="Mayberry 1987" TYPE="JOURNAL_ARTICLE">
<AU>Mayberry JF, Atkinson M</AU>
<TI>Variations in the prevalence of achalasia in Great Britain and Ireland: an epidemiological study based on hospital admissions</TI>
<SO>Quarterly Journal of Medicine</SO>
<YR>1987</YR>
<VL>62</VL>
<PG>67-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ritvo-1940" MODIFIED="2010-02-03 18:21:22 +0000" MODIFIED_BY="[Empty name]" NAME="Ritvo 1940" TYPE="JOURNAL_ARTICLE">
<AU>Ritvo M, McDonald EJ</AU>
<TI>Value of nitrates in cardiospasm (achalasia of esophagus): preliminary report</TI>
<SO>American Journal of Roentgenology</SO>
<YR>1940</YR>
<VL>43</VL>
<PG>500-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tottrup--1991" MODIFIED="2010-02-03 18:20:40 +0000" MODIFIED_BY="[Empty name]" NAME="Tottrup  1991" TYPE="JOURNAL_ARTICLE">
<AU>Tottrup A, Svane D, Forman A</AU>
<TI>Nitric oxide mediating NANC inhibition in opossum lower esophageal sphincter</TI>
<SO>American Journal of Physiology</SO>
<YR>1991</YR>
<VL>260</VL>
<PG>G385-G389</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES MODIFIED="2010-02-03 17:49:48 +0000" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2010-02-10 11:47:36 +0000" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2010-02-10 11:47:36 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2010-02-03 17:56:29 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gelfond-1982">
<CHAR_METHODS MODIFIED="2010-02-03 17:56:27 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised blind cross over controlled trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-02-03 17:56:28 +0000" MODIFIED_BY="[Empty name]">
<P>6 men, 9 women, mean age 44 yrs.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-02-03 17:56:29 +0000" MODIFIED_BY="[Empty name]">
<P>Isosorbide dinitrate 5mg v. nifedipine 20mg sublingually.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-02-03 17:56:29 +0000" MODIFIED_BY="[Empty name]">
<P>LOS pressure; radiolabelled test meal of oesophageal retention.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-02-03 18:07:36 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wong-1987">
<CHAR_METHODS MODIFIED="2010-02-03 17:57:20 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised blind cross over controlled trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-02-03 18:07:36 +0000" MODIFIED_BY="[Empty name]">
<P>11 men, 4 women. Mean age 28 years.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-02-03 18:07:32 +0000" MODIFIED_BY="[Empty name]">
<P>Nitroglycerin 0.4 mg s.l. and normal saline 0.25ml s.c.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-02-03 17:57:35 +0000" MODIFIED_BY="[Empty name]">
<P>LOS pressure; radiolabelled test meal of oesophageal retention.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>i.v. intravenous</P>
<P>s.l. sub lingual</P>
<P>s.c. sub cutaneous</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2010-02-03 18:03:42 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2010-02-03 17:58:41 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Achkar-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 17:58:41 +0000" MODIFIED_BY="[Empty name]">
<P>Review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-03 17:59:07 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Allescher-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 17:59:07 +0000" MODIFIED_BY="[Empty name]">
<P>Review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-03 17:59:26 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bassotti-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 17:59:26 +0000" MODIFIED_BY="[Empty name]">
<P>No control</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-03 17:59:08 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bassotti-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 17:59:08 +0000" MODIFIED_BY="[Empty name]">
<P>Review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-03 17:59:28 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bortolotti-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 17:59:28 +0000" MODIFIED_BY="[Empty name]">
<P>Non-randomized controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-03 17:59:44 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bourgeois-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 17:59:44 +0000" MODIFIED_BY="[Empty name]">
<P>No intervention with nitrates</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-03 17:59:36 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Douthwaite-1943">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 17:59:36 +0000" MODIFIED_BY="[Empty name]">
<P>Non-randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-03 17:59:48 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Efrati-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 17:59:48 +0000" MODIFIED_BY="[Empty name]">
<P>Case-report</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-03 18:03:40 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ferguson-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 18:03:40 +0000" MODIFIED_BY="[Empty name]">
<P>Performed on participants with chest pain</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-03 17:59:54 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Furuya-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 17:59:54 +0000" MODIFIED_BY="[Empty name]">
<P>Case-report</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-03 18:00:39 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gelfond-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 18:00:39 +0000" MODIFIED_BY="[Empty name]">
<P>No control</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-03 18:00:42 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ghosh-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 18:00:42 +0000" MODIFIED_BY="[Empty name]">
<P>No control</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-03 17:59:08 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hildebrand-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 17:59:08 +0000" MODIFIED_BY="[Empty name]">
<P>Review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-03 18:00:01 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kikendall-1980">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 18:00:01 +0000" MODIFIED_BY="[Empty name]">
<P>Study performed on healthy volunteers</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-03 18:00:04 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Krivchenya-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 18:00:04 +0000" MODIFIED_BY="[Empty name]">
<P>No control medication</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-03 18:00:06 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ona-1980">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 18:00:06 +0000" MODIFIED_BY="[Empty name]">
<P>Case report</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-03 17:59:09 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Reynolds-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 17:59:09 +0000" MODIFIED_BY="[Empty name]">
<P>Review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-03 18:00:26 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rozen-1982a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 18:00:26 +0000" MODIFIED_BY="[Empty name]">
<P>No control</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-03 18:00:21 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rozen-1982b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 18:00:21 +0000" MODIFIED_BY="[Empty name]">
<P>No control</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-03 17:59:10 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schroeder-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 17:59:10 +0000" MODIFIED_BY="[Empty name]">
<P>Review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-03 18:03:41 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Stanley-1955">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 18:03:41 +0000" MODIFIED_BY="[Empty name]">
<P>A group of participants with cardiospasm were given urecholine, dibuline, and finally nitroglycerin. The author did not provide the exact time interval between each medicine and did not provide exactly how long after nitroglycerin intake participants were measured for oesophageal emptying.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-03 17:59:11 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Storr-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 17:59:11 +0000" MODIFIED_BY="[Empty name]">
<P>Review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-03 18:03:42 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Swamy-1977">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 18:03:42 +0000" MODIFIED_BY="[Empty name]">
<P>Performed on participants with esophageal spasm, no control medication.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-03 17:59:12 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tack-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 17:59:12 +0000" MODIFIED_BY="[Empty name]">
<P>Review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-03 17:59:12 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Traube-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 17:59:12 +0000" MODIFIED_BY="[Empty name]">
<P>Review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-03 17:59:13 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vaezi-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 17:59:13 +0000" MODIFIED_BY="[Empty name]">
<P>Review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-03 18:01:59 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-03 18:01:59 +0000" MODIFIED_BY="[Empty name]">
<P>No control medication</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2010-02-10 11:47:36 +0000" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2010-02-10 11:47:36 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-02-03 17:56:48 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gelfond-1982">
<DESCRIPTION>
<P>Quote: "each received at random either ID or Nif sublingually".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-02-10 11:47:36 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wong-1987">
<DESCRIPTION>
<P>Quote: On four separate days, participants received one of four medications "in a random order".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2010-02-03 18:07:53 +0000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-02-03 18:03:34 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Gelfond-1982">
<DESCRIPTION>
<P>Quote: "Because of the different routes of drug administration, the participants were not blinded as to whether they received ID or Nif".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-02-03 18:07:53 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wong-1987">
<DESCRIPTION>
<P>The four medications were given by different way, either s.l., s.c., or i.v.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2010-02-03 18:09:28 +0000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>clinical response</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.02" NO="2">
<NAME>Manometric examinations</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-02-03 17:56:45 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gelfond-1982">
<DESCRIPTION>
<P>Quote: "the clinical response was assessed by the physician without knowing or asking which medication was given".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2010-02-03 17:56:51 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gelfond-1982">
<DESCRIPTION>
<P>Quote:"Analysis of the manometric examinations was made without knowing which drug was administered.".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-02-03 18:03:37 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wong-1987">
<DESCRIPTION>
<P>Did not report clinical response for every participant.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2010-02-03 18:09:28 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wong-1987">
<DESCRIPTION>
<P>Quote: "After studying 15 participants, recordings of individual station pull-throughs were removed from the entire tracing, coded, randomised, and read by a single un-informed observer."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2010-02-03 17:58:18 +0000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-02-03 17:56:55 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gelfond-1982">
<DESCRIPTION>
<P>No incomplete outcome data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-02-03 17:58:18 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wong-1987">
<DESCRIPTION>
<P>Yes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2010-02-03 18:03:38 +0000" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-02-03 17:56:58 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gelfond-1982">
<DESCRIPTION>
<P>Yes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-02-03 18:03:38 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wong-1987">
<DESCRIPTION>
<P>Did not report clinical response for every participant.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2010-02-03 17:58:24 +0000" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-02-03 17:57:01 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gelfond-1982">
<DESCRIPTION>
<P>Yes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-02-03 17:58:24 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wong-1987">
<DESCRIPTION>
<P>Yes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES"/>
<FIGURES/>
<FEEDBACK/>
<APPENDICES MODIFIED="2009-04-10 13:46:59 +0100" MODIFIED_BY="Cathy Bennett">
<APPENDIX ID="APP-01" MODIFIED="2009-04-10 13:46:59 +0100" MODIFIED_BY="Cathy Bennett" NO="1">
<TITLE MODIFIED="2009-04-10 13:46:57 +0100" MODIFIED_BY="Cathy Bennett">MEDLINE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2009-04-10 13:46:59 +0100" MODIFIED_BY="Cathy Bennett">
<P>1. exp nitrates/<BR/>2. nitrat$.tw.<BR/>3. exp isosorbide dinitrate/<BR/>4. (isosorbide adj3 dinitrate).tw.<BR/>5. pentaerythrit$.tw.<BR/>6. exp nitroglycerin/<BR/>7. nitrogly$.tw.<BR/>8. (glyceryl adj3 trinitrate).tw.<BR/>9. exp amyl nitrite/<BR/>10. (amyl adj3 nitr?te).tw.<BR/>11. or/1-10<BR/>12. exp esophageal achalasia/<BR/>13. achal$.tw.<BR/>14. cardiospasm$.tw.<BR/>15. (spas$ adj5 cardia).tw.<BR/>16. (megaesophagus or megaoesophagus).tw.<BR/>17. or/12-16<BR/>18. 11 and 17<BR/>19. limit 18 to yr="2005 - 2008"</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>